Global Blood Therapeutics Company Profile

12:10 EST 16th December 2018 | BioPortfolio

Global Blood Therapeutics is a product-focused company building a pipeline of innovative, oral medicines to revolutionize the treatment of chronic blood-based diseases and genetic disorders for which there are currently no available cures and only extremely limited therapeutic options. The company’s SHAPE Platform enables the discovery and development of oral, small molecule drugs that change the shapes of key blood proteins to modify their functions, enhance vital biological pathways and drive therapeutic benefits. Global Blood Therapeutics’ approach combines the most advanced computational biology and protein-ligand modeling with medicinal chemistry and empiric screening capabilities focused on allosteric modulation, while leveraging its team’s world-leading expertise in blood biology and proven success in drug discovery and development. Global Blood Therapeutics is a private company launched in 2012 by Third Rock Ventures with an experienced leadership team and renowned scientific founders. For more information, please visit

News Articles [2351 Associated News Articles listed on BioPortfolio]

Global Blood licenses sickle cell candidate from Roche

Global Blood Therapeutics acquired rights to Roche Holding's inclacumab, which Global Blood will develop to treat vaso-occlus -More- 

Global Blood Therapeutics' sickle cell disease drug succeeds in trial

(Reuters) - U.S. biotech company Global Blood Therapeutics Inc said on Wednesday its experimental drug met the main goal of a late-stage trial in patients with sickle cell disease, a potentially life-...

Public offering nets $141mm for Global Blood Therapeutics

Global Blood Therapeutics Inc. netted $141mm through a public offering of 3.4mm common shares at $44. The company is developing treatments for sickle cell diseases and will use the proceeds to fund co...

Small-Cap Snapshot: Galectin Therapeutics flies after receiving a patent for treating pulmonary fibrosis

Aquinox Pharmaceuticals, Summit Therapeutics and Global Blood Therapeutics are also making news

Roche partners discontinued inclacumab with Global Blood Therapeutics

Global Blood Therapeutics Inc. (GBT) received exclusive worldwide rights, and sublicensing rights, to develop, manufacture, and commercialize Roche’s preclinical fully human monoclonal antibody incl...

STAT Plus: Global Blood’s FDA filing plan for a sickle cell drug is riskier than you think

Global Blood Therapeutics is taking an unprecedented regulatory gamble to win approval for a new drug to treat sickle cell disease. Are investors underestimating the risk that this effort blows…

Positive Top-line Data Achieved From Phase 3 Sickle Cell Disease Study

NewsGlobal Blood Therapeutics, Inc. announced the completion of a planned review of Part A of the Phase 3 HOPE Study, which is evaluating voxelotor for the treatment of sickle cell disease (SCD).

Oppenheimer analyst Mark Breidenbach expects FDA approval for Global Blood Therapeutics' sickle cell drug

Oppenheimer & Co Equity Research Senior Analyst Mark Breidenbach tells Proactive Investors that Global Blood Therapeutics (NASDAQ:GBT) reported results Wednesday for its sickle cell disease drug...

PubMed Articles [3262 Associated PubMed Articles listed on BioPortfolio]

A Novel Approach for Therapeutic Delivery to the Rodent Pancreas Via Its Arterial Blood Supply.

Endovascular techniques can now access the arterial blood supply of the pancreas in humans to enable therapeutics to reach the gland in high concentrations while concurrently avoiding issues related t...

May Measurement Month 2017: an analysis of blood pressure screening results worldwide.

Increased blood pressure is the biggest contributor to the global burden of disease and mortality. Data suggest that less than half of the population with hypertension is aware of it. May Measurement ...

A review of blood usage and wastage in a tertiary heart center.

Blood is a vital resource that its utilization is ever increasing throughout the world and blood wastage is a global challenge that needs to be controlled. Most blood resources are used during complic...

Effect of perindopril and bisoprolol on IL-2, INF-γ, hs-CRP, and T-cell stimulation and its correlations with blood pressure in mild and moderate hypertension

Cardiovascular disease is the leading global cause of death. Its development is largely determined by lifestyle and cardiovascular risk factors, among which arterial hypertension (HT) plays a key role...

Angubindin-1 opens the blood-brain barrier in vivo for delivery of antisense oligonucleotide to the central nervous system.

Within the field of RNA therapeutics, antisense oligonucleotide-based therapeutics are a potentially powerful means of treating intractable diseases. However, if these therapeutics are used for the tr...

Clinical Trials [4885 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Global Congestive Heart Failure Registry

Heart failure (HF) is a major health problem worldwide but there is no global HF study that documents demographics, socioeconomic and clinical factors, diagnostic and management patterns, ...

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

Cryo AF Global Registry

Cryo AF Global Registry a prospective, global, multi-center, observational Post-Market Registry

Companies [2805 Associated Companies listed on BioPortfolio]

Global Blood Therapeutics

Global Blood Therapeutics is a product-focused company building a pipeline of innovative, oral medicines to revolutionize the treatment of chronic blood-based diseases and genetic...


For more than 30 years, Haemonetics has been a global leader in blood processing technology. The Company has two families of products:Donor Products - These products are marketed to the blood donation...

ZymeQuest Incorporated

ZymeQuest, a development stage company, is the global leader in the discovery, development and commercialization of enzymatic blood conversion products for use in blood transfusion medicine. Our enzym...

Synthetic Blood International, Inc

Synthetic Blood International, Inc. (OTC BB: SYBD) is a cutting edge biomedical product development company specializing in creating innovative pharmaceuticals and medical devices in the fields of oxy...


CaridianBCT is the leading global provider of innovative technologies and services specializing in automated blood collections, therapeutic apheresis and cell therapy systems, who...

More Information about "Global Blood Therapeutics" on BioPortfolio

We have published hundreds of Global Blood Therapeutics news stories on BioPortfolio along with dozens of Global Blood Therapeutics Clinical Trials and PubMed Articles about Global Blood Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Global Blood Therapeutics Companies in our database. You can also find out about relevant Global Blood Therapeutics Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Corporate Database Quicklinks

Searches Linking to this Company Record